Kiniksa Pharmaceuticals International Plc (KNSA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
26.97 +1.09 (+4.21%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 26.80 -0.17 (-0.63%) 18:06 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | KNSA | JANX | ARWR | ||
| Company | Kiniksa Pharmaceuticals International Plc | Janux Therapeutics Inc | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.02 | 31.99 | 13.12 | ||
| High | 27.53 | 33.51 | 14.24 | ||
| Low | 25.60 | 31.78 | 13.00 | ||
| Last | 26.97 | 33.20 | 13.89 | ||
| Change | +1.09 | +0.65 | +0.42 | ||
| % Change | +4.21% | +2.00% | +3.12% | ||
| Volume | 1,484,500 | 938,900 | 1,674,400 | ||
| 20-Day Average Volume | 759,475 | 948,605 | 2,117,015 | ||
| Previous Close | 25.88 | 32.55 | 13.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 21.07 | 29.00 | 12.15 | ||
| 20-Day Raw Stochastic | 93.99% | 97.18% | 92.51% | ||
| 20-Day Relative Strength | 70.30% | 56.03% | 50.16% | ||
| Weighted Alpha | +28.94 | -53.99 | -53.56 | ||
| Today's Opinion | 24% Buy | 56% Sell | 88% Sell | ||
| Previous Opinion | 16% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +29.17% since 04/23/25 | +5.00% since 04/23/25 | +6.76% since 04/23/25 | ||
| Low | 20.19 on 04/25/25 | 30.20 on 04/25/25 | 12.81 on 04/24/25 | ||
| High | 27.53 on 04/30/25 | 33.51 on 04/30/25 | 14.24 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | +16.80% since 03/28/25 | +14.09% since 03/28/25 | +0.51% since 03/28/25 | ||
| Low | 18.25 on 04/09/25 | 22.52 on 04/09/25 | 9.57 on 04/07/25 | ||
| High | 27.53 on 04/30/25 | 33.51 on 04/30/25 | 14.24 on 04/30/25 | ||
| 3-Month | |||||
| %Chg | +35.66% since 01/30/25 | -25.88% since 01/30/25 | -31.34% since 01/30/25 | ||
| Low | 18.12 on 02/11/25 | 22.52 on 04/09/25 | 9.57 on 04/07/25 | ||
| High | 27.53 on 04/30/25 | 46.10 on 01/31/25 | 21.84 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | +17.21% since 10/30/24 | -40.66% since 10/30/24 | -29.53% since 10/30/24 | ||
| Low | 17.82 on 01/13/25 | 22.52 on 04/09/25 | 9.57 on 04/07/25 | ||
| High | 27.53 on 04/30/25 | 71.71 on 12/05/24 | 27.34 on 11/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,880,026 | 1,925,918 | 1,849,660 | ||
| Shares Outstanding, K | 72,644 | 59,168 | 137,317 | ||
| Annual Sales | 423,240,000 | 10,590,000 | 3,550,000 | ||
| Annual Net Income | -43,190,000 | -68,990,000 | -599,490,000 | ||
| Last Quarter Sales | 122,540,000 | 440,000 | 2,500,000 | ||
| Last Quarter Net Income | -8,890,000 | -28,060,000 | -173,090,000 | ||
| 60-Month Beta | 0.31 | 3.27 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 04/29/25 | -0.36 on 02/27/25 | -1.39 on 02/10/25 | ||
| Latest Earnings Date | 04/29/25 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||